Background: Interstitial lung disease associated with rheumatoid arthritis (RA-ILD) is linked
to high morbidity and mortality.[1] The gold standard for the diagnosis of RA-ILD is a high …

Background ILD is a significant complication of RA, but diagnosis of RA-ILD is often delayed
as respiratory symptoms do not develop until the disease is advanced. Several risk factors …

Background: Interstitial lung disease (ILD) remains underestimated in patients with
rheumatoid arthritis (RA). Despite the increased mortality associated with RA-ILD, guidelines …

Background Interstitial lung disease (ILD) in Rheumatoid Arthritis (RA) can be subclinical or
underestimated. Data from the literature report male sex, seropositivity and old age as …

Objectives To evaluate the differences between patients with rheumatoid arthritis (RA) with
and without interstitial lung disease (ILD), to identify factors associated with the development …

Background: Interstitial lung disease (ILD) in rheumatoid arthritis (RA) is an extra-
musculoskeletal manifestation with high mortality. Early detection could improve the quality …

Background Interstitial lung disease (ILD) can have a significant impact on the long-term
outcome in patients with rheumatoid arthritis (RA) but international screening guidelines for …

Background Despite a high morbi-mortality rate, there are no definite strategy for subclinical
interstitial lung disease (ILD) screening in patients with rheumatoid arthritis (RA). Objectives …

Background: Interstitial lung disease (ILD) in Rheumatoid Arthritis (RA) is associated with
increased mortality, and methods of detection are warranted [1]. It is generally …

Background: Seropositive and ACPA positive Rheumatoid Arthritis (RA) is correlated with
notable cardiovascular and pulmonary comorbidity 1, 2. Objectives: Nevertheless, there is …